Home Applications 218860 Application 218860
Type NDA
Sponsor IPSEN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 IQIRVO ELAFIBRANOR TABLET;ORAL 80MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218860-001 IQIRVO ELAFIBRANOR 80MG TABLET / ORAL RLD, RS 2024-06-10
Orange Book patents# Current patent rows page 1 of 1 · 9 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218860-001 11185519 2037-03-30 U-3955 2024-06-25 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 N218860-001 12233038 2037-03-30 U-1854 2025-03-12 N218860-001 12295927 2037-03-30 U-1854 2025-06-03 N218860-001 12295928 2037-03-30 U-1854 2025-06-03 N218860-001 12310935 2037-03-30 U-1854 2025-06-03 N218860-001 12589086 2037-03-30 U-4473 2026-04-09
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N218860-001 NCE 2029-06-10 N218860-001 ODE-486 2031-06-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 301d65b070ca…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218860-001 IQIRVO 80MG TABLET / ORAL RLD, RS 2024-06-10 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218860-001 11185519 2037-03-30 U-3955 2024-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 12233038 2037-03-30 U-1854 2025-03-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 12295927 2037-03-30 U-1854 2025-06-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 12295928 2037-03-30 U-1854 2025-06-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218860-001 12310935 2037-03-30 U-1854 2025-06-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 11185519 2037-03-30 U-3955 2024-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 12233038 2037-03-30 U-1854 2025-03-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 12295927 2037-03-30 U-1854 2025-06-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 12295928 2037-03-30 U-1854 2025-06-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218860-001 12310935 2037-03-30 U-1854 2025-06-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218860-001 11185519 2037-03-30 U-3955 2024-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 12233038 2037-03-30 U-1854 2025-03-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 12295927 2037-03-30 U-1854 2025-06-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 12295928 2037-03-30 U-1854 2025-06-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218860-001 12310935 2037-03-30 U-1854 2025-06-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218860-001 11185519 2037-03-30 U-3955 2024-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218860-001 12233038 2037-03-30 U-1854 2025-03-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218860-001 11185519 2037-03-30 U-3955 2024-06-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 7632870 2024-09-09 Drug product 2024-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 7943661 2024-09-09 Drug substance, Drug product 2024-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 11185519 2037-03-30 U-3955 2024-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 11331292 2037-03-30 U-1854 2024-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 11850223 2037-03-30 U-1854 2024-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218860-001 11857523 2037-03-30 U-3955 2024-06-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218860-001 7632870 2024-09-09 Drug product 2024-06-25 2680178bc6a6…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join IQIRVO ELAFIBRANOR Ipsen Biopharmaceuticals, Inc. d78aa14f-6ec1-4b1d-a4ae-e48658137a25 2024-06-10 Warnings, Adverse reactions Exact identifier application applno (NDA): 218860 application number: NDA218860
Documents# Document, Submission type, Date table Document Submission type Date 79194 ORIG 2024-07-24 78766 ORIG 2024-06-11 78761 ORIG 2024-06-11